Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation for inhibiting formation of 5-HT2B agonists and methods of using same

Formulation for inhibiting formation of 5-HT2B agonists and methods of using same

US Patent 11786487 · Granted Oct 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2023
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2023
Metabolism resistant fenfluramine analogs and methods of using the same2023
Metabolism resistant fenfluramine analogs and methods of using the same2023
Ketogenic diet compatible fenfluramine formulation2022
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2022
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2022
Metabolism resistant fenfluramine analogs and methods of using the same2022
Metabolism resistant fenfluramine analogs and methods of using the same2022
Compositions and methods involving polymer, solvent, and high viscosity liquid c2022
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2021
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2021